Parameters | Our study | Mandalos et al
15 J Glaucoma, 2016 | Tai et al
14 JAAPOS, 2014 | Van Overdam et al
12 Br J Ophthalmol, 2006 | de Moura et al
13 Am J Ophthalmol, 2005 | Budenz et al
11 Ophthalmology, 2004 |
Study design | Prospective, non-comparative | Retrospective, non-comparative | Retrospective, non-comparative | Retrospective, non-comparative | Retrospective, non-comparative | Retrospective, non-comparative |
GDD used | AADI (ligature) No stent/MMC | BGI or Molteno stent; MMC | BGI | BGI | BGI | BGI (50–1 stage; 12–2 stage) |
Patients | <16 years (31 eyes; 34) | <18 years (69 eyes; 52) | <19 years (46 eyes; 35) | <16 years (55 eyes; 40) | <16 years (48 eyes; 48) | <18 years (62 eyes; 62) |
Average age | 8.22 ±−3.61 years | 8.3 ±−5.1 years | 5 months to 19 years | 3.3±3.6 years | 4.1±4.9 years | 6.5±5.2 years |
Study period | 2013–2015 | 2004–2011 | 2000–2010 | 1998–2003 | 1990–1999 | Not defined |
Minimum follow-up Average follow-up | 6 months 18.3±6.9 months | 6 months 45.7±25.2 months | 3 months | 2 months 31.9±18.9 months | 4 months Median 21 months | 6 months 24.8±2.5 months |
Efficacy (success rates IOP 6–21 mm Hg) | 100%, 6 months 91.18%, 1 year 81.7%, 18 months 81.7% 2 years | 95.6%, 1 year 71.3%, 5 years 39.7%, 8 years | 93.3%, 3–9 months 86.7%, 1 year 86.7%, 2 years | 94%, 1 year 94%, 2 years 85%, 3 years 78%, 4 years | 95.0 %, 6 months 90.5%, 1 year 87.2%, 18 months 83.7%, 2 years 74.4% 3 years | 87%, 6 months 82%, 1 year 68%, 2 years |
Complications requiring intervention | Cataract: 3 (8.8%) Retinal detachment: 1 | Cataract: 23% Encapsulation: 16.4% Endophthalmitis: 5.8% | BGI replacement: 2 No LP: 1 | Cataract: 3 Phthisis: 2 | Cataract: 10% Vitreous haemorrhage: 8.3% Retinal detachment: 2 | Tube exposure: 1 Retinal detachment: 5 Endophthlamitis: 1 Phthisis: 1 |
AADI, Aurolab aqueous drainage implant; BDI, Baerveldt glaucoma implant; GDD, glaucoma drainage device; MMC, mitomycin C.